Navigation Links
Global Non-Hematological Cancers Market to Hit $140.8 Billion by 2021, says GBI Research
Date:4/8/2016

LONDON, April 8, 2016 /PRNewswire/ --

A new report from business intelligence provider GBI Research - Global Non-Hematological Cancers Market to 2021 - states that the global treatment market for non-hematological cancers, which includes breast, colorectal, lung and prostate cancers, among others, will almost double from $72.9 billion in 2014 to $140.8 billion in 2021, at a compound annual growth rate (CAGR) of 9.9%.

This robust growth will occur in spite of the patent expiries of a number of very commercially successful products, including Avastin, Erbitux and Herceptin. Avastin will see its first expiry in the EU in 2018, with the two others having already experienced EU expiries in 2014.

Associate Analyst Adam Bradbury explains: "These drugs are all monoclonal Antibodies (mAbs), and are therefore expected to be less susceptible to market share and price erosion following patent expiry, due to practical and regulatory barriers to entry for biosimilars. In this way, these expirations will not pose too strong a barrier to growth."

Market drivers will include the increasing prevalence of cancer globally, and the introduction of more targeted treatments, which will improve the overall survival of poor-performance-status patients and enable more rounds of chemotherapy to be administered.

GBI Research also states that in terms of the pharmaceutical pipeline for non-hematological cancers, there are 2,954 products in active development, 171 of which are in Phase III development or Pre-registration.

Bradbury explains: "Although none of the products in the late-stage pipeline are expected to reach the same levels of success as the highest revenue-generating drugs currently in the market, due to the competitiveness of the landscape, there are a number of candidates that are expected to achieve strong sales during the forecast period. These include AZD-4736 and neratinib, which are both forecast to generate blockbuster revenues by 2021.

"A range of companies are actively involved in the development or marketing of these new oncology products, including most of the top 20 pharmaceutical companies, smaller publicly traded companies and privately-held enterprises. In particular, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, and Novartis, are anticipated to maintain their strong market shares throughout the forecast period.

"While Roche's market share within non-blood cancers is anticipated to decrease, partly due to the approaching patent expiries of Avastin and Tarceva, Roche is still expected to maintain the highest market share for non-hematological cancer treatment of any company throughout the forecast period."

Sample pages of GBI Research's report Global Non-Hematological Cancers Market to 2021 are available upon request

About GBI Research 

GBI Research is a leading provider of business intelligence reports, offering actionable data and forecasts based on the insights of key healthcare industry influencers to ensure you stay up-to-date with the latest market trends. For more information about our offerings, please contact us on:

+44-(0)161-359-5817 

Connect with GBI Research on social media for the latest healthcare market updates:

Facebook | LinkedIn | Twitter


'/>"/>
SOURCE GBI Research
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Alzheimer Disease Report 2016 - New Drugs, Markets and Companies to 2025 Featuring 300+ Different Compounds at Various Stages of Development - Research and Markets
2. Global Nitric Oxide Therapeutics, Markets and Companies Study 2016 with Projections to 2020 & 2025 - Research and Markets
3. Global Animal Biotechnology Technologies, Markets and Companies Report 2016 - Research Activities of 11 Veterinary and Livestock Research Institutes With 108 Collaborations - Research and Markets
4. Global Gene Therapy Technologies, Markets and Companies Report 2016 - Analysis & Forecasts 2015-2025 - Research and Markets
5. Global Medication Adherence Market Expected to Grow With 17.5% CAGR During 2016-2022: P&S Market Research
6. Global Ultrasound Market Growth Steady at 5.5% CAGR to 2020
7. Global Age-Related Macular Degeneration Market Expected to Grow at 7.6% CAGR During 2016-2022: P&S Market Research
8. Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report
9. Knee Cartilage Repair Market Projected to Reach US$ 2.7 Billion Globally in 2023: Transparency Market Research
10. Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results
11. Peripheral Neuropathy (Sensory) Market Pipeline Global Review H2 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... ... “When Seconds Count: Reports From an Emergency Medical Helicopter Pilot”: a powerful read ... the real stories of the EMS flight crew. “When Seconds Count: Reports From an ... EMS helicopter pilot. He has been a pilot in the HEMS industry for twelve ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Eric ... awareness of their advanced dental and medical training to offer medically compromised ... patients with heart conditions, diabetes, and other systemic concerns for dental implants and ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... Fresno resident ... Donate Life Rose Parade® Float living donor honoree. Regina will walk alongside the float, ... Day. , Regina, a retired nurse and attorney, became a living organ donor in ...
Breaking Medicine Technology:
(Date:10/17/2019)... DALLAS (PRWEB) , ... October 17, 2019 , ... A ... the 2019 PRS Best Cosmetic Surgery Paper Award at Plastic Surgery - The Meeting ... Core Study Results at 6 Years,” was authored by Larry S. Nichter, M.D., Robert ...
(Date:10/15/2019)... ... ... Khalieghya Dandie-Evans, a liver transplant recipient from Richmond, Calif. was chosen by ... the 131st Rose Parade® on New Year’s Day. She will represent the thousands of ... organization’s service area. , Khalieghya, 17, grew up believing it was “normal” to have ...
(Date:10/15/2019)... ... October 15, 2019 , ... Labeling for ... Guidance , **An FDAnews Webinar**, Tuesday, October 29, 2019, 1:30-3:00 p.m. EDT, ... have on new drug applications and biologics license applications? , How will the ...
(Date:10/15/2019)... (PRWEB) , ... October 15, 2019 , ... Genomenon® ... partnership with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search ... puts the most up-to-date genomic research at the fingertips of clinical researchers performing genomic ...
(Date:10/11/2019)... DAYTON, Ohio (PRWEB) , ... October 11, 2019 , ... ... Children’s has three of them, as well as a female physician leading the ... role models for today’s girls who want to succeed in traditionally male-oriented fields. , ...
Breaking Medicine News(10 mins):